Triheptanoin

• CAS: 620-67-7
• Catalog Number: ACM620677
• Category: Other Products
• Molecular Weight: 428.6
• Molecular Formula: C24H44O6
• Synonyms: Glyceroltriheptanoate,1,2,3-propanetriylester
• IUPAC Name: 2,3-Di(heptanoyloxy)propyl heptanoate
• SMILES: CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC
• InChI: InChI=1S/C24H44O6/c1-4-7-10-13-16-22(25)28-19-21(30-24(27)18-15-12-9-6-3)20-29-23(26)17-14-11-8-5-2/h21H,4-20H2,1-3H3
• InChI Key: PJHKBYALYHRYSK-UHFFFAOYSA-N
• Boiling Point: 200 °C
• Flash Point: 195.5 °C
• Density: 0.966 g/mL at 20 °C(lit.)
• Appearance: Colorless liquid
• Storage: Freezer
• Active Content: 95%
• Assay: 0.99
• Complexity: 421
• Exact Mass: 428.31378912
• Hazard Statements: Xi
• Monoisotopic Mass: 428.31378912
• Packaging: 1 kg
• Physical State: Liquid
• Refractive Index: n20/D 1.444
• Stability: Stable. Incompatible with strong oxidizing agents.
• Topological Polar Surface Area: 78.9 Ų

Custom Q&A

What is the molecular formula of Triheptanoin?

The molecular formula of Triheptanoin is C24H44O6.

When was Triheptanoin granted FDA approval?

Triheptanoin was granted FDA approval on June 30, 2020.

What is the IUPAC Name of Triheptanoin according to PubChem?

The IUPAC Name of Triheptanoin is 2,3-di(heptanoyloxy)propyl heptanoate.

How many hydrogen bond acceptor counts does Triheptanoin have?

Triheptanoin has 6 hydrogen bond acceptor counts.

What is the exact mass of Triheptanoin?

The exact mass of Triheptanoin is 428.31378912 g/mol.

What is the topological polar surface area of Triheptanoin?

The topological polar surface area of Triheptanoin is 78.9 ².

What is the UNII identifier for Triheptanoin?

The UNII identifier for Triheptanoin is 2P6O7CFW5K.

How many synonyms are listed for Triheptanoin?

There are several synonyms listed for Triheptanoin, including Trioenanthoin and Trienanthoin.

What is the CAS number for Triheptanoin?

The CAS number for Triheptanoin is 620-67-7.

How are complications reduced in patients with long chain fatty acid oxidation disorders when treated with Triheptanoin?

Complications in patients with long chain fatty acid oxidation disorders are reduced from approximately 60% to approximately 10% with the addition of Triheptanoin.